key: cord-0844893-fnifv71o
authors: Ebrille, Elisa; Lucciola, Maria Teresa; Amellone, Claudia; Ballocca, Flavia; Orlando, Fabrizio; Giammaria, Massimo
title: Syncope as the presenting symptom of COVID-19 infection
date: 2020-05-05
journal: HeartRhythm Case Rep
DOI: 10.1016/j.hrcr.2020.04.015
sha: 189ed2f7355e349af2d27e27366184127964a428
doc_id: 844893
cord_uid: fnifv71o

nan

The severity of COVID-19 symptoms can range from none, to very mild or severe. They usually 2 appear 2 to 14 days after virus exposure and can include fever, cough, shortness of breath, 3 headache, diarrhea, vomiting, runny nose, sore throat, anosmia and ageusia, conjunctivitis, 4 tiredness and aches. 1 To our knowledge, syncope alone has not been described as a symptom 5 associated with COVID-19 infection. We report a case series of syncope as the presenting 6 symptom in otherwise asymptomatic patients with COVID-19 infection. vision. In the ED his blood pressure (BP) was 115/75 mmHg, heart rate (HR) 75 bpm, oxygen 15 saturation (O 2 Sat) 98% on room air. His device was interrogated and showed normal functioning, 16 regular parameters and no arrhythmias. In order to be admitted on a regular Medicine floor he 17 was tested for COVID-19 infection. His nasopharyngeal swab resulted positive. His chest X-Ray was 18 unremarkable (Figure 1, panel A) . He was placed on isolation precautions and after 4 days he 19 developed a fever; subsequently, right lobe pneumonia was diagnosed on chest X-Ray (Figure 1 , 20 panel B). 21 22

A 65-year-old female, with history of mitral valve stenosis status post valve replacement with a 1 bio-prosthesis 13 years before, PPM implanted for advanced atrio-ventricular (AV) block at the 2 time of cardiac surgery and history of atrial fibrillation (AF), had a traumatic syncope preceded by 3 lightheadedness. She did not seek medical attention at the time of syncope. Ten days after, she 4 presented to the ED complaining of fever (101.5 F) and shortness of breath. Oxygen saturation 5 was 93% on room air. Chest X-Ray showed multiple rib fractures with associated moderate pleural with presyncope and diaphoresis, which resolved after fluid challenge. Transthoracic 23 echocardiogram ruled out pericardial effusion. Chest X-Ray was within normal limits ( Figure 3 , 24 panel A). He was discharged home asymptomatic the following day. Two days after, he presented 1 again to the ED because of a syncope preceded by a similar vagal reaction. The ICD worked 2 properly, and no arrhythmias were found. Chest X-Ray showed an area of lung dysventilation in 3 the right lower lobe (Figure 3, panel B) . CT scan of the chest confirmed bilateral pneumonia, with 4 multiple ground-glass opacities with subpleural distribution (Figure 3, panel C) . He was tested 5 again for COVID-19 infection and resulted positive. We reported a case series of patients presenting with syncope as the only initial symptom of 10 COVID-19 infection. To our knowledge, this finding has not been systematically described in the 11

Syncope may be a very common chief complaint of patients presenting to the ED, with a broad 13 differential diagnosis. 2 Patients with syncope, especially when deemed vasovagal or orthostatic, 14 are usually dismissed from the ED after a thorough clinical history evaluation. Our case series 15 showed how syncope may be the presenting symptom of a very serious illness. 16

The mechanism behind the occurrence of syncope in COVID-19 has not been described. In our 17 case series, cardiac syncope with tachy-or brady-arrhythmia as the primary cause has been 18 excluded, since all patients had a PPM or an ICD showing no abnormalities. Syncope due to 19 structural cardiac disease or pulmonary embolism has been ruled out as well. The proposed 20 pathophysiological explanation might be a neurally mediated/reflex mechanism in its non-classical 21 form (absence of certain trigger) or an autonomic dysfunction, either primary or secondary. There 22

are two main pathophysiological mechanisms in reflex syncope, both of them depending from an 23 imbalance between sympathetic and parasympathetic activity: vasodepression, caused by 24 insufficient sympathetic vasoconstriction, and cardioinhibition, caused by parasympathetic 1

predominance. This type of imbalance might find another confirming factor in the association 2 between COVID-19 infection and "inappropriate" sinus tachycardia which often characterizes 3 patients with Coronavirus infection even in the absence of respiratory failure. 3 4

The autonomic failure hypothesis, on the other hand, might involve a primary failure caused by 5 the virus itself or a secondary failure due to autoimmune autonomic neuropathy. The occurrence 6 of neurologic features in COVID-19 infection has been recently documented, in terms of 7 encephalopathy and corticospinal tract involvement. 4-5 However, determining if this is a direct 8 effect of the virus or if it is due to a critical autoimmune reaction or inflammation caused by 9

cytokines is still a matter of debate. Cytokine storm with subsequent hyper-inflammation is one of 10 the proposed mechanisms of COVID-19 serious illness. 6 Vascular injury caused by IL-1 and IL-6 11

and decreased systemic vascular resistance resulting in vasodilation could be one of the possible 12 explanations of syncope as the resulting symptom. 7 13

Finally, 4 out of 5 patients in our series were on chronic therapy with angiotensin-converting 14 enzyme (ACE) inhibitors. Whether ACE-inhibitors, upregulating ACE-2 expression in many tissues 15 and therefore facilitating virus binding to the cells, predispose to COVID-19 infection has not been 16 proved. [8] [9] However, the overall decrease in the vasopressor effect of Angiotensin II in patients 17 treated with ACE-inhibitors might play a role in the pathophysiology of syncope. 18

Further studies with larger sample size are necessary before drawing definite conclusions on the 19 mechanism of syncope as the presenting symptom of COVID-19 infection. However, recognizing 20 this possibility is of extreme importance, especially in the initial phase of COVID-19 infection, 21

when the transmission rate might be very high and maximum isolation precautions are not in 22 place yet. 23 7 1

We reported a case series of patients presenting with syncope as the only initial symptom of 3 COVID-19 infection. Whether the exact mechanism is still debated, recognizing this possibility is of 4 utmost importance for undertaking appropriate isolation precaution and possibly to treat patients 5 when the infection is still at its initial phase. 6 with multiple ground-glass opacities and subpleural distribution. 7

Clinical Characteristics of Coronavirus Disease 2019 in China

ESC Guidelines for the diagnosis and 4 management of syncope

Guidance for Cardiac Electrophysiology

During the Coronavirus (COVID-19) Pandemic from the Heart Rhythm Society

Task Force; Electrophysiology Section of the American College of Cardiology

Electrocardiography and Arrhythmias Committee of the Council on

Central nervous system manifestations of COVID-19: A 11 systematic review

Neurologic Features in Severe SARS-CoV-2 Infection

The role of cytokines including 15 interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-Like 16 disease

Inflammatory cytokines in vascular dysfunction and vascular 18 disease

Cardiovascular Pharmacology in the Time of COVID-20 19: A Focus on Angiotensin Converting Enzyme 2

Renin Angiotensin System Blockers

• Syncope alone has never been described as a symptom associated with COVID-19 infection

Whether the exact mechanism is still debated, recognizing this possibility is of utmost importance for undertaking appropriate isolation precaution

• Its early recognition might help COVID-19 treatment, fighting the infection at its initial phase